NCT05004571View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of EQU-001 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

July 6, 2021

Primary Completion Date

September 4, 2021

Study Completion Date

September 4, 2021

Conditions
Safety Issues
Interventions
DRUG

EQU-001

EQU-001 in 10 and 20 mg capsules

DRUG

Placebo

Matched placebo

Trial Locations (1)

33104

Clinical Pharmacology of Miami, Hialeah

Sponsors
All Listed Sponsors
lead

Equilibre Biopharmaceuticals B.V.

INDUSTRY